L.I. MALTSEVA¹, YU.V. GARIFULLOVA¹, M.E. ZHELEZOVA²

 ¹Kazan State Medical Academy — Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan

²Kazan (Volga) Federal University, Kazan

Contact details:

Maltseva L.I. — MD, Professor, Professor of the Department of Obstetrics and Gynecology

Address: 36 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-905-314-40-51, e-mail: laramalc@mail.ru

The article presents a modern view of the vaginal microbiome from the perspective of assessing its condition and impact on a woman’s health. The microbiome of a healthy European woman is dominated by lactobacilli with powerful antibacterial properties, while black and Latin American women have non-lactobacillar biocenosis with minimal protective properties, which creates a special predisposition to inflammatory and even neoplastic processes. The article reflects the available data on the association of vaginal dysbiosis with a number of gynecological diseases — endometriosis, polycystic ovaries, infertility, gynecological cancer (of cervix, endometrium, ovaries, and mammary glands), pregnancy complications (ectopic pregnancy, miscarriage, premature birth, preeclampsia and gestational diabetes mellitus). In these cases, vaginal dysbiosis not only reflects problems in the reproductive tract, but also exacerbates the pathology. The focus is on new data on the relationship of vaginal biocinosis and its disorders with other organs: gastrointestinal tract, urinary system, joints, and brain. Full-fledged restoration of biocenosis is promising for the prevention and treatment of many women’s diseases.

Key words: vaginal microbiome, dysbiosis, pregnancy complications, somatic health.

(For citation: Maltseva L.I., Garifullova Yu.V., Zhelezova M.E. Vaginal microbiota as a reflection of a woman’s health. Practical medicine. 2025. Vol. , № , P.)

REFERENCES

1. Thomas S. Döderlein’s Bacillus: Lactobacillus Acidophilus. J. Infect. Dis, 1928, vol. 43, pp. 218–227.
2. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S.K., Mc Culle S.L. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA, 2011,  vol. 108 (1),  pp. 4680–4687.
3. France M.T., Ma B., Gajer P., Brown S., Humphrys M.S., Holm J.B. et al. Valencia: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome, 2020,  vol. 8,  p. 166.
4. Adapen C., Réot L., Menu E. The role of human vaginal microbiota in the regulation of inflammation and acquisition of sexually transmitted infections: does a non-human primate model contribute to a better understanding? Front. Reprod. Health, 2022,  vol. 4,  992176. DOI: 10.3389/frph.2022.992176
5. Spurbeck R.R., Arvidson C.G. Surface-associated proteins from Lactobacillus jensenii inhibit adhesion of Neisseria gonorrhoeae to epithelial cells. Infect. Immun, 2010,  vol. 78 (7),  pp. 3103–3111. DOI: 10.1128/IAI.01200-09
6. Borgdorff H., Gautam R., Armstrong S.D., Xia D., Ndayisaba G.F., van Teijlingen N.H. et al. Cervical and vaginal microbiome dysbiosis is associated with proteome alterations linked to alterations in the cervical and vaginal mucosal barrier. Mucosal Immunol, 2016,  vol. 9 (3),  pp. 621–633. DOI: 10.1038/mi.2015.86
7. Sharifian K., Shoja Z., Jalilvand S. Vzaimodeystvie virusa papillomy cheloveka i mikrobioty vlagalishcha v razvitii raka sheyki matki. Virol. J, 2023,  vol. 20 (1),  p. 73. DOI: 10.1186/s12985-023-02037-8
8. Cancer incidence and survival in major ethnic groups. England, 2002–2006, available at: www.ncin.org.uk/view?rid=75
9. O’Hanlon D.E., Moench T.R., Cone R.A. In vaginal fluid, bacteria that cause bacterial vaginosis can be inhibited by lactic acid but not by hydrogen peroxide. BMC Infect. Dis, 2011,  vol. 11,  p. 200.
10. Virginia J., Glick∙Cecilia A., Webber∙Lauren E. et al. Activity Vaginal lactobacilli produce anti-inflammatory β-carboline compounds. Cell Host Microbe, 2024,  vol. 32 (11),  1897–1909. DOI: 10.1016/j.chom.2024.09.014
11. Zheng N., Guo R., Wang J., Zhou W., Lin Z. Contribution of Lactobacillus Iners to vaginal health and disease: a systematic review. Front. Cell Infect. Microbiol, 2021,  vol. 11,  p. 1177.
12. Dubé-Zinatelli E., Cappelletti L., Ismail N. Vaginal microbiome: environmental, biological, and racial influences on gynecological health across the lifespan. Am. J. Reprod. Immunol, 2024,  vol. 92 (6),  p. e70026. DOI: 10.1111/aji.70026
13. Gao H., Liu Q., Wang X., Li T., Li H., Li G. et al. Deciphering the role of the female reproductive tract microbiome in reproductive health: a review. Front. Cell Infect. Microbiol, 2024,  vol. 14,  1351540. DOI: 10.3389/fcimb.2024.1351540
14. Cortés-Ortiz I.A., Acosta-Altamirano G., Nambo-Venegas R., Pineda-Migranas J.A., Rios-Hernández O.G., García-Moncada E. et al. Vaginal dysbiosis in infertility: a comparative analysis of women with primary and secondary infertility. Microorganisms, 2025,  vol. 13 (1),  p. 188. DOI: 10.3390/microorganisms13010188
15. Maksimovic Celicanin M., Haahr T., Humaidan P., Skafte-Holm A. Vaginal dysbiosis — the association with reproductive outcomes in IVF patients: a systematic review and meta-analysis. Curr. Opin. Obstet. Gynecol, 2024,  vol. 36 (3),  pp. 155–164. DOI: 10.1097/GCO.0000000000000953
16. Fu M., Zhang X., Liang Y., Lin S., Qian W., Fan S. Vaginal microbiota and associated metabolome changes in women with recurrent implantation failure. mBio, 2020,  vol. 11 (3),  e03242-19. DOI: 10.1128/mBio.03242-19
17. Ata B., Yildiz S., Turkgeldi E., Brocal V. P., Dinleyici E.C., Moya A., Urman B. Endobiota study: comparison of vaginal, cervical, and intestinal microbiota in women with stage 3/4 endometriosis and healthy controls. Sci. Rep, 2019,  vol. 9,  p. 2204.
18. Sobstyl A., Chałupnik A., Mertowska P., Grywalska E. How do microorganisms influence the development of endometriosis? Involvement of genital, intestinal and oral microbiota in the regulation of metabolism and immunopathogenesis of endometriosis. Int. J. Mol. Sci, 2023,  vol. 24 (13),  p. 10920. DOI: 10.3390/ijms241310920
19. Gu Y., Zhou G., Zhou F., Li Y., Wu Q., He H. et al. Gut and vaginal microbiomes in PCOS: implications for women’s health. Front. Endocrinol, 2022,  vol. 13,  808508. DOI: 10.3389/fendo.2022.808508
20. Sola-Leyvaa A., Perez-Prieto I., Molinaa N.M., Vargasa E., Ruiz-Duranb S., Leones-Banos Irene et al. Microbial composition in different body sites in polycystic ovary syndrome: a systematic review and meta-analysis. Reprod. Biomed. Online, 2023,  vol. 47 (1),  pp. 129–150.
21. Bonab F.R., Baghbanzadeh A., Ghaseminia M., Bolandi N., Mokhtarzadeh A., Amini M. et al. Molecular pathways in HPV-induced cervical cancer development. EXCLI J, 2021,  vol. 20,  p. 320. DOI: 10.17179/excli2021-3365
22. Pappa K.I., Ligirou V., Kontostati G., Zoidakis J., Makridakis M., Vougas K. et al. Proteomic analysis of normal and cancer cervical cell lines reveals dysregulation of cytoskeleton-associated proteins. Cancer Genom. Proteomics, 2017,  vol. 14 (4),  pp. 253–266. DOI: 10.21873/cgp.20036
23. Alimena S., Davis J., Fichorova R.N., Feldman S. The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer. Curr. Probl. Cancer, 2022,  vol. 46 (4),  100877. DOI: 10.1016/j.currproblcancer.2022.100877
24. Loonen A.J.M., Verhagen F., Luijten-de Vrije I., Lentjes-Beer M., Huijsmans C.J., van den Brule A.J.C. Vaginal dysbiosis appears to be associated with hrHPV infection in women attending a Dutch cervical cancer screening program. Cell. Infect. Microbiol, 2024,  vol. 14,  1330844. DOI: 10.3389/fcimb.2024.1330844
25. Sofou E., Gkoliou G., Pechlivanis N., Pasentsis K., Chatzistamatiou K., Psomopoulos F. et al. High risk HPV-positive women cervicovaginal microbial profiles in a Greek cohort: a retrospective analysis of the GRECOSELF study. Front. Microbiol, 2023,  vol. 14,  1292230. DOI: 10.3389/fmicb.2023.1292230
26. Zhou C.-W., Long H.-Q., Cheng Y., Luo H.-Y., Wen D.-D., Gao L.-C. From microbiome to inflammation: key drivers of cervical cancer (review). Front. Microbiol, 2021,  vol. 12,  767931. DOI: 10.3389/fmicb.2021.767931
27. Ivanov M.K., Brenner E.V., Hodkevich A.A., Dzyubenko V.V., Krasilnikov S.E., Mansurova A.S. et al. Cervicovaginal-microbiome analysis by 16S sequencing and real-time PCR in patients from Novosibirsk (Russia) with cervical lesions and several years after cancer treatment. Diagnostics (Basel), 2023,  vol. 13 (1),  p. 140. DOI: 10.3390/diagnostics13010140
28. Avitabile E., Menotti L., Croatti V., Giordani B., Parolin C., Vitali B. Defense mechanisms of vaginal lactobacilli against sexually transmitted viral infections. Int. J. Mol. Sci, 2024,  vol. 25 (17),  p. 9168. DOI: 10.3390/ijms25179168
29. Li Y., Yu T., Yan H., Li D., Yu T., Yuan T. et al. Vaginal microbiota and HPV infection: novel mechanistic insights and therapeutic strategies. Infect. Drug. Resist, 2020, vol. 13,  pp. 1213–1220. DOI: 10.2147/IDR.S210615
30. Nené N.R., Reisel D., Leimbach A., Franchi D., Jones A., Evans I. et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and ovarian cancer risk: a case-control study. Lancet Oncol, 2019,  vol. 20,  pp. 1171–1182. DOI: 10.1016/S1470-2045(19)30340-7
31. Chen L., Zhai Y., Wang Y., Fearon E.R., Núñez G., Inohara N., Cho K.R. Microbiome alteration suppresses tumorigenesis in a mouse model of oviductal high-grade serous carcinoma. Cancer Res, 2021,  vol. 81,  pp. 3309–3318. DOI: 10.1158/0008-5472.CAN-21-0106
32. Nami Y., Abdullah N., Haghshenas B., Radiah D., Rosli R., Yari Khosroushahi A. A newly isolated probiotic strain of Enterococcus faecalis from vaginal microbiota enhances apoptosis of human cancer cells. J. Appl. Microbiol, 2014,  vol. 117,  pp. 498–508. DOI: 10.1111/jam.12531
33. Jia D., Nagaoka Y., Katsumata M., Orsulik S. Inflammation is a key factor promoting ovarian cancer cell seeding. Sci. Rep, 2018,  vol. 8,  12394. DOI: 10.1038/s41598-018-30261-8
34. Zhao X., Liu Z., Chen T. potential role of vaginal microbiota in ovarian cancer carcinogenesis, progression and treatment. Pharmaceutics, 2023,  vol. 15 (3),  p. 948. DOI: 10.3390/pharmaceutics15030948
35. Hakimjavadi H., George S.H., Taub M., Dodds L.V., Sanchez-Covarrubias A.P., Huang M. et al. The vaginal microbiome is associated with endometrial cancer grade and histology. Cancer Res. Commun, 2022,  vol. 2 (6),  pp. 447–455. DOI: 10.1158/2767-9764.CRC-22-0075
36. Walsh D., Hokenstad A., Chen J., Sun J., Jenkins G., Chia N. et al. Postmenopause as a key factor in the composition of the endometrial cancer microbiome (ECbiome). Sci. Rep, 2019,  vol. 9,  p. 19213.
37. Lu W., He F., Lin Z., Liu S., Tang L., Huang Y. et al. Endometrial microbiota dysbiosis and its association with inflammatory cytokines in endometrial cancer. Int. J. Cancer, 2021,  vol. 147,  pp. 1708–1716.
38. Lai T., Wang K., Hou Q., Zhang J., Yuan J., Yuan L. et al. Interleukin 17 induces increased chemokine and cytokine expression via activation of nuclear factor κB and extracellular signal-regulated kinase 1/2 pathways in gynecologic cancer cell lines. Int. J. Gynecol. Cancer, 2011,  vol. 21,  pp. 1533–1539.
39. Che Q., Liu B., Wang F., He Y., Lu W., Liao Y. et al. Interleukin 6 promotes endometrial cancer growth via an autocrine feedback loop involving the ERK-NFκB signaling pathway. Biochem. Biophys. Res. Commun, 2014,  vol. 446,  pp. 167–172.
40. Balmaganbetova F.K., Amanzholkyzy A., Nurgaliyeva R.E., Kaldybayeva A.T., Zhexenova A.N. Comparative Analysis of vaginal microbiota in women with breast cancer in Kazakhstan. Asian Pac. J. Cancer Prev, 2021,  vol. 22 (4),  pp. 1313–1318. DOI: 10.31557/APJCP.2021.22.4.1313